RxDoctor Payments Data

Joseph Hamati, MD

Anesthesiology · Midwest City, OKNPI 1033599410

Payments from drug & device makers

What this record shows

15 manufacturers reported payments, led by Boston Scientific at 42.8% of the total. Reporting peaked in 2019 at $1,244 and has fallen 98.8% since, to $15 in 2025. Among anesthesiology clinicians in OK with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$2,338in general payments, 2019–2025

Across 38 payments — averaging $61.53 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Boston Scientific$1000
  • Medtronic$535
  • Nevro Corp.$250
  • Pacira Pharmaceuticals Incorporated$122
  • Merck$102
  • Si-bone, Inc.$81
  • plus $248 from 9 others

What the payments were for

  • Travel & lodging$1,02044%
  • Food & beverage$1,31856%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$2,338 in reported general payments places this provider in the 95th percentile of 476 anesthesiology providers in Oklahoma.

See all anesthesiology providers in Oklahoma

Medicare billing

Part B allowed, 2024
$172,571
Medicare patients
245
Services billed
2,347

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
PercocetOxycodone Hcl/Acetaminophen15$69,686
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen554$14,759
Xtampza ErOxycodone Myristate12$14,709
BelbucaBuprenorphine Hcl14$11,232
OxycontinOxycodone Hcl13$6,011
Methocarbamol188$4,947
Gabapentin258$4,459
Tizanidine Hcl187$4,389
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen101$4,061
Buprenorphine18$3,625
Lidocaine19$2,806
Pregabalin79$1,238
Naloxone Hcl17$1,191
Baclofen98$1,179
Oxycodone Hcl97$1,079

Paid to pharmacies, not to this prescriber.

Other anesthesiology in Midwest City

See the full list for Oklahoma

Where these figures come from

Is this you, or does something look wrong? →